LNDR Fundamental Analysis - LANDI RENZO SPA

Fundamental Rating

LNDR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 30 industry peers in the Automobile Components industry. LNDR may be in some trouble as it scores bad on both profitability and health. LNDR is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year LNDR has reported negative net income.

In the past year LNDR had a positive cash flow from operations.

1.2 Ratios

LNDR's Return On Assets of -14.49% is on the low side compared to the rest of the industry. LNDR is outperformed by 93.33% of its industry peers.

Looking at the Return On Equity, with a value of -87.98%, LNDR is doing worse than 93.33% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-14.49%
ROE	-87.98%
ROIC	N/A

ROA(3y)-4.4%

ROA(5y)N/A

ROE(3y)-23.41%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

LNDR has a Gross Margin (38.63%) which is in line with its industry peers.

LNDR's Gross Margin has declined in the last couple of years.

LNDR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	38.63%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.5%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

LNDR does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for LNDR remains at a similar level compared to 1 year ago.

LNDR has a worse debt/assets ratio than last year.

2.2 Solvency

LNDR has an Altman-Z score of 1.27. This is a bad value and indicates that LNDR is not financially healthy and even has some risk of bankruptcy.

LNDR's Altman-Z score of 1.27 is on the low side compared to the rest of the industry. LNDR is outperformed by 76.67% of its industry peers.

LNDR has a Debt/Equity ratio of 1.53. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 1.53, LNDR is not doing good in the industry: 73.33% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	1.53
Debt/FCF	N/A
Altman-Z	1.27

ROIC/WACCN/A

WACC6.45%

2.3 Liquidity

A Current Ratio of 1.17 indicates that LNDR should not have too much problems paying its short term obligations.

LNDR has a Current ratio (1.17) which is in line with its industry peers.

LNDR has a Quick Ratio of 1.17. This is a bad value and indicates that LNDR is not financially healthy enough and could expect problems in meeting its short term obligations.

LNDR has a worse Quick ratio (0.73) than 76.67% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.17
Quick Ratio	0.73

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

LNDR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -681.63%.

The Revenue has decreased by -7.88% in the past year.

LNDR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.88% yearly.

EPS 1Y (TTM)-681.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1218.94%

Revenue 1Y (TTM)-7.88%

Revenue growth 3Y28.88%

Revenue growth 5YN/A

Sales Q2Q%-15.08%

3.2 Future

Based on estimates for the next years, LNDR will show a very strong growth in Earnings Per Share. The EPS will grow by 24.27% on average per year.

LNDR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.84% yearly.

EPS Next Y59.46%

EPS Next 2Y35.57%

EPS Next 3Y24.27%

EPS Next 5YN/A

Revenue Next Year-8.32%

Revenue Next 2Y-1.37%

Revenue Next 3Y0.74%

Revenue Next 5Y6.84%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LNDR. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LNDR. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as LNDR's earnings are expected to grow with 24.27% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y35.57%

EPS Next 3Y24.27%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for LNDR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

LANDI RENZO SPA

BIT:LNDR (11/18/2025, 7:00:00 PM)

0.831

+0.01 (+1.22%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupAutomobiles & Components

GICS IndustryAutomobile Components

Earnings (Last)11-13 2025-11-13

Earnings (Next)03-10 2026-03-10

Inst Owners0.81%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap35.75M

Revenue(TTM)420.45M

Net Income(TTM)-48.02M

Analysts42.22

Price Target1.53 (84.12%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.09
P/FCF	N/A
P/OCF	6.07
P/B	0.66
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-1.57

EYN/A

EPS(NY)-0.2

Fwd EYN/A

FCF(TTM)-0.11

FCFYN/A

OCF(TTM)0.14

OCFY16.48%

SpS9.77

BVpS1.27

TBVpS-1.13

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.49%
ROE	-87.98%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	38.63%
FCFM	N/A

ROA(3y)-4.4%

ROA(5y)N/A

ROE(3y)-23.41%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.5%

GM growth 5YN/A

F-Score4

Asset Turnover1.27

Health

		Industry Rank	Sector Rank
Debt/Equity	1.53
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	67.19%
Cap/Sales	2.51%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.17
Quick Ratio	0.73
Altman-Z	1.27

F-Score4

WACC6.45%

ROIC/WACCN/A

Cap/Depr(3y)54.84%

Cap/Depr(5y)N/A

Cap/Sales(3y)3.18%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-681.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1218.94%

EPS Next Y59.46%

EPS Next 2Y35.57%

EPS Next 3Y24.27%

EPS Next 5YN/A

Revenue 1Y (TTM)-7.88%

Revenue growth 3Y28.88%

Revenue growth 5YN/A

Sales Q2Q%-15.08%

Revenue Next Year-8.32%

Revenue Next 2Y-1.37%

Revenue Next 3Y0.74%

Revenue Next 5Y6.84%

EBIT growth 1Y-30.97%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year117.87%

EBIT Next 3Y43.14%

EBIT Next 5Y36.73%

FCF growth 1Y-1125.44%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-612.11%

OCF growth 3YN/A

OCF growth 5YN/A

LANDI RENZO SPA / LNDR.MI FAQ

Can you provide the ChartMill fundamental rating for LANDI RENZO SPA?

ChartMill assigns a fundamental rating of 2 / 10 to LNDR.MI.

What is the valuation status of LANDI RENZO SPA (LNDR.MI) stock?

ChartMill assigns a valuation rating of 1 / 10 to LANDI RENZO SPA (LNDR.MI). This can be considered as Overvalued.

How profitable is LANDI RENZO SPA (LNDR.MI) stock?

LANDI RENZO SPA (LNDR.MI) has a profitability rating of 1 / 10.

How financially healthy is LANDI RENZO SPA?

The financial health rating of LANDI RENZO SPA (LNDR.MI) is 1 / 10.

What is the expected EPS growth for LANDI RENZO SPA (LNDR.MI) stock?

The Earnings per Share (EPS) of LANDI RENZO SPA (LNDR.MI) is expected to grow by 59.46% in the next year.

LANDI RENZO SPA (LNDR.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

LANDI RENZO SPA / LNDR.MI FAQ

Can you provide the ChartMill fundamental rating for LANDI RENZO SPA?

What is the valuation status of LANDI RENZO SPA (LNDR.MI) stock?

How profitable is LANDI RENZO SPA (LNDR.MI) stock?

How financially healthy is LANDI RENZO SPA?

What is the expected EPS growth for LANDI RENZO SPA (LNDR.MI) stock?